Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NCCAM Sponsoring First Glucosamine/Chondroitin Sulfate Multicenter Study

This article was originally published in The Tan Sheet

Executive Summary

NCCAM is sponsoring the first U.S. multicenter study investigating the "short-term (16 weeks) effectiveness of glucosamine and chondroitin sulfate in reducing pain and improving function in a large number of patients with osteoarthritis of the knee," the National Institutes of Health National Center for Complementary & Alternative Medicine announced.

You may also be interested in...



Glucosamine/Chondroitin Supplier Selection Delays NIH Study

Difficulty in choosing a U.S. company to supply glucosamine and chondroitin sulfate has delayed the start of the NIH-funded study on osteoarthritis.

Glucosamine/Chondroitin Supplier Selection Delays NIH Study

Difficulty in choosing a U.S. company to supply glucosamine and chondroitin sulfate has delayed the start of the NIH-funded study on osteoarthritis.

Glucosamine/Chondroitin Supplier Selection Delays NIH Study

Difficulty in choosing a U.S. company to supply glucosamine and chondroitin sulfate has delayed the start of the NIH-funded study on osteoarthritis.

Related Content

Topics

UsernamePublicRestriction

Register

PS090336

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel